Evidence map›Paper›PMID 32679651›Full record

SynthesisMolecules (Basel, Switzerland)2020

Jeysson Sánchez-Suárez, Ericsson Coy-Barrera, Luisa Villamil, Luis Díaz

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Microbiology spectrum · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Antioxidant and Enzyme Inhibitory Potential ofInternational journal of microbiology · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Marine drugs · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeysson Sánchez-SuárezDoctoral Program of Biosciences, School of Engineering, Universidad de La Sabana, Chía 140013, Cundinamarca, Colombia.ORCID 0000-0001-8708-411X
Ericsson Coy-BarreraBioorganic Chemistry Laboratory, Universidad Militar Nueva Granada, Bogotá 110111, Cajicá, Cundinamarca, Colombia.ORCID 0000-0002-3553-9749
Luisa VillamilDoctoral Program of Biosciences, School of Engineering, Universidad de La Sabana, Chía 140013, Cundinamarca, Colombia.
Luis DíazDoctoral Program of Biosciences, School of Engineering, Universidad de La Sabana, Chía 140013, Cundinamarca, Colombia.ORCID 0000-0002-9588-9935

Funding

Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS) 80740-168-2019Universidad de La Sabana ING-175-2016
6 · The paper itself

Abstract

Sun overexposure is associated with the development of diseases that primarily affect the skin, which can lead to skin cancer. Among the main measures of photoprotection is the use of sunscreens. However, there is currently concern about the reported harmful effects to both humans and the environment due to several of the sunscreen ingredients available on the market. For this reason, the search for and development of new agents with photoprotective properties is required. In searching for these metabolites, researchers have turned their attention to microbial sources, especially the microbiota in unusual hostile environments. Among the diverse microorganisms available in nature, Actinobacteria and specifically

Indexed as

AntioxidantsBiological ProductsHumansSecondary MetabolismStreptomycesStructure-Activity RelationshipSunscreening AgentsUltraviolet RaysAntioxidantsBiological ProductsSunscreening Agentsactinobacteriaanti-inflammatoryantioxidant activityphotoprotectionStreptomycessunscreenUV-absorbing

Identifiers

PMID32679651
PMCPMC7397340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.